Skip to main content
DHTI
OTC Trade & Services

Dalrada Settles $1.16M IBS Dispute for $20,000, Releases All Liens and Equity Claims

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
8
Price
$0.009
Mkt Cap
$1.093M
52W Low
$0.002
52W High
$0.099
52W Position info
314% above low
Off High info
91% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

DHTI has more than doubled off its 52-week low of $0.002 on light trading volume (0.2× avg).

Summary

Dalrada settled the IBS financing dispute for $20,000, terminating all financing documents and releasing all liens, guaranties, and equity claims. The $1.16M demand was withdrawn and no amounts remain owing.


Key Events · Legal and Risk Events · DHTI

  • Settlement Resolves $1.16M IBS Dispute

    Dalrada paid IBS a single lump-sum of $20,000 on October 2, 2026, to settle all claims arising from the Financing Documents and IBS Notices that had demanded approximately $1,162,246.

  • All Financing Documents Terminated

    The MGA, MCSPA, guaranties, pledges, deposit account control agreement, secured promissory note, and pre-funded warrant were all terminated and discharged effective at closing.

  • Liens and Equity Claims Released

    All liens, security interests, and account-control rights granted to IBS were released, and IBS confirmed it holds no shares, warrants, options, or other equity or purchase rights in Dalrada or its subsidiaries.

  • CEO Personal Guaranty Released

    Brian Bonar's personal guaranty and the corporate guaranty of Dalrada were terminated and released, removing personal exposure for the CEO.


Analysis · DHTI · Trade & Services

Dalrada resolved the IBS default dispute for $20,000 — roughly 1.7% of the $1.16M demanded — and secured full termination of all financing documents, release of all liens and security interests, and cancellation of the pre-funded warrant. This removes a significant contingent liability and equity overhang from a company already facing going-concern risk and a material weakness in controls. The settlement also releases CEO Brian Bonar's personal guaranty and confirms IBS holds no equity or purchase rights in Dalrada or its subsidiaries.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DHTI was trading at $0.01 on OTC in the Trade & Services sector, with a market capitalization of approximately $1.1M. The 52-week trading range was $0.00 to $0.10. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DHTI - Latest Insights

DHTI
Sep 22, 2026, 4:58 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0092
Real-time Price: $0.0128 info
Change: +$0.0036 (+39%) info
Market Cap: $1.538M info
DHTI
May 21, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.0311
Real-time Price: $0.0128 info
Change: -$0.0183 (-59%) info
Market Cap: $1.538M info
DHTI
May 20, 2026, 7:16 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0311
Real-time Price: $0.0128 info
Change: -$0.0183 (-59%) info
Market Cap: $1.538M info
DHTI
Apr 07, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $0.0421
Real-time Price: $0.0128 info
Change: -$0.0293 (-70%) info
Market Cap: $1.538M info
DHTI
Apr 02, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
7
Price at Filing: $0.0421
Real-time Price: $0.0128 info
Change: -$0.0293 (-70%) info
Market Cap: $1.538M info